期刊文献+

IL-28B基因多态性与慢性丙型肝炎患者肝纤维化的相关性研究 被引量:4

Association between IL-28B gene polymorphisms and liver fibrosis in patients with chronic hepatitis C
下载PDF
导出
摘要 目的探讨IL-28B基因多态性与慢性丙型肝炎(chronic hepatitisC,CHC)患者肝纤维化的相关性。方法选择65例CHC患者(男34例,女31例),检测患者rs12979860和rs8099917两个位点的基因型,并用瞬时弹性波扫描(FibroScan,FS)检测患者肝纤维化程度,分析这两个位点与肝纤维化的关系。结果 rs12979860和rs8099917两个位点的基因型与FS值的关系无统计学意义;但患者年龄(t=4.062,P=0.000)及感染时年龄(t=3.068,P=0.003)与FS值相关。结论 IL-28B基因对CHC患者肝纤维化的影响不显著。但患者年龄及感染时的年龄可能与CHC患者肝纤维化有关。 Objective To investigate the association between interleukin (IL)-28B gene polymorphisms and liver fibrosis in patients with chronic hepatitis C (CHC). Methods A total of 65 CHC patients were enrolled in the study, among whom 34 were males and 31 were females. The rs12979860 and rs8099917 were detected by PCR and sequencing. FibroScan was applied in these patients to assess the degree of liver fibrosis, and the relationship between the two sites and liver fibrosis was analyzed. Results rs- 12979860 and rs8099917 polymorphisms were not significantly associated with the FibroScan measurements. However, age(t= 4.062, P=O.O00) and the age at infection with HCV (t=3.068, P=O.O03) were significantly associated with FibroScan measurements. Conclusions Genetic variation in IL-28B don't affect liver fibrosis significantly in CHC patients, but age and the age at infection with HCV may be significantly associated with liver fibrosis.
出处 《传染病信息》 2012年第2期93-95,共3页 Infectious Disease Information
基金 国家"十一五"科技重大专项(2008ZX10002-013 2009-ZX1005-016)
关键词 丙型肝炎 白细胞介素-28B 多态现象 遗传学 肝纤维化 hepatitis C interleukin-28B polymorphism, genetic liver fibrosis
  • 相关文献

参考文献11

  • 1Ge D,Fellay J,Thom pson AJ,et al.Genetic variation in IL28B predicts hepatitis C treatm ent-induced viralclearance[J].Nature,2009,461(7262):399-401.
  • 2Thom as DL,Thio CL,M artinM P,et al.Genetic variation in IL28B and spontaneousclearanceofhepatitisC virus[J].Nature,2009,461(7265):798-801.
  • 3Suppiah V,M oldovan M,Ahlenstiel G,et al.IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy[J].NatGenet,2009,41(10):1100-1104.
  • 4Tanaka Y,Nishida N,Sugiyam a M,et al.Genom e-wide association ofIL28B with response to pegylated interferon-alpha and ribavirin therapy forchronic hepatitis C[J].NatGenet,2009,41(10):11051109.
  • 5Castéra L,VerqniolJ,Foucher J,et al.Prospective com parison of transient elastography,Fibrotest,APRI,and liver biopsy for the assessm ent of fibrosis in chronic hepatitis C[J].Gastroenterology,2005,128(2):343-350.
  • 6丙型肝炎防治指南[J].传染病信息,2004,17(1). 被引量:30
  • 7FalletiE,Bitetto D,Fabris C,et al.Role ofinterleukin28B rs12979860C/T polym orphism on the histological outcom e of chronic hepatitis C:relationship with gender and viralgenotype[J].J Clin Im m unol,2011,31(5):891-899.
  • 8Fabris C,FalletiE,Cussigh A,et al.The interleukin28B rs12979860C/T polym orphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently norm altransam inases[J].JM ed Virol,2012,84(5):747-755.
  • 9M arabita F,Aghem o A,De Nicola S,et al.Genetic variation in the interleukin-28B gene is notassociated with fibrosis progression in patients with chronic hepatitis C and known date of infection[J].H epatology,2011,54(4):1127-1134.
  • 10Rao H Y,Sun DG,Yang RF,et al.Outcom e of hepatitis C virus infection in Chinese paid plasm a donors:a12-19-yearcohortstudy[J].J GastroenterolH epatol,2012,27(3):526-532.

共引文献29

同被引文献46

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部